Timi is a news and deals writer who's been reporting on technology for over a decade. He loves breaking down complex subjects into easy-to-read pieces that keep you informed. But his recent passion ...
The FDA has updated the safety labeling for axicabtagene ciloleucel (Yescarta, Kite Oncology) — a CAR T-cell therapy — extending its indication to include patients with relapsed or refractory primary ...
FDA labeling now permits axi-cel use in R/R PCNSL, making it the first CAR T for R/R LBCL with CNS lymphoma limitations removed. Phase 1 Dana-Farber study (N=18; PCNSL n=13) prioritized ...
– Limitations of Use Removed for Rare and Aggressive Form of non-Hodgkin Lymphoma Based on Manageable Safety Profile with No New Safety Signals Identified – Primary central nervous system lymphoma is ...
WASHINGTON, D.C. — Diabetes patients who use certain TRUE METRIX blood glucose meters are being urged to review updated safety instructions after manufacturer ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
(RTTNews) - Kite, a Gilead Company (GILD), announced the FDA approved an update to the Yescarta prescribing information removing the previous Limitations of Use in patients with relapsed or refractory ...
The FDA has updated the product labeling of capecitabine (Xeloda, Genentech) and fluorouracil to reflect the risks of acute toxicity and potentially fatal adverse reactions in patients with ...
FDA strengthens capecitabine and 5‑FU labels: DPD deficiency can trigger fatal toxicity; consider testing, lower doses, and prompt antidote. The FDA has updated the safety labeling for the ...
New guidelines clarify labeling, allowing foods dyed with natural sources while keeping synthetic dyes off the label. Winter storm warning for 11 states as up to 4 feet of snow forecast Person shoots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results